Literature DB >> 2466576

A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins.

L A Goldstein1, D F Zhou, L J Picker, C N Minty, R F Bargatze, J F Ding, E C Butcher.   

Abstract

Lymphocyte interactions with high endothelial venules (HEV) during extravasation into lymphoid tissues involve an 85-95 kd class of lymphocyte surface glycoprotein(s), gp90Hermes (CD44). We report here the cloning of cDNA for gp90Hermes expressed in a mucosal HEV-binding B lymphoblastoid cell line, KCA. Northern hybridization revealed the presence of three invariant RNA bands at 1.5, 2.2, and 4.5 kb in mucosal HEV-, lymph node HEV-, or dual-binding cells. The deduced amino acid sequence predicts a mature protein with a C-terminal cytoplasmic tail, a hydrophobic transmembrane domain of 23 amino acids, and an N-terminal extracellular region of 248 amino acids. A proximal extracellular domain is the probable region of O-glycosylation and chondroitin sulfate linkage and displays at least two of the three immunodominant epitope clusters of native gp90Hermes. A distal region contains the majority of potential N-glycosylation sites and cysteines, and exhibits a striking homology to tandemly repeated domains of the cartilage link and proteoglycan core proteins. No significant similarities were found to the immunoglobulin, integrin, or cadherin gene families. Thus gp90Hermes represents a novel class of integral membrane protein involved in lymphocyte-endothelial cell interactions and lymphocyte homing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466576     DOI: 10.1016/0092-8674(89)90639-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  137 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

2.  Molecular cloning of chicken aggrecan. Structural analyses.

Authors:  L Chandrasekaran; M L Tanzer
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

3.  A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin.

Authors:  L Y Bourguignon; V B Lokeshwar; J He; X Chen; G J Bourguignon
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 4.  Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration.

Authors:  Robert Sackstein
Journal:  Ann Biomed Eng       Date:  2011-11-09       Impact factor: 3.934

Review 5.  Lymphocyte homing into the gut.

Authors:  S Jalkanen
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding.

Authors:  R Hyman; J Lesley; R Schulte
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Immunostaining of a heterodimeric dermatan sulphate proteoglycan is correlated with smooth muscles and some basement membranes.

Authors:  J C Schittny; H Kresse; P H Burri
Journal:  Histochem Cell Biol       Date:  1995-04       Impact factor: 4.304

8.  Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican.

Authors:  M Romarís; A Bassols; G David
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae.

Authors:  H Nakamura; S Kenmotsu; H Sakai; H Ozawa
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

10.  Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules.

Authors:  H Yang; R M Binns
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.